Cargando…
Intravenous Honokiol in Drug-Resistant Cancer: Two Case Reports
Context: Long-term patient survival in cancer is affected by drug resistance. Honokiol (HNK) is a small-molecule polyphenol isolated from the bark and seed cones of Magnolia officinalis. HNK has been shown to enhance the effects of chemotherapy and inhibit drug resistance in preclinical models. HNK...
Autores principales: | Eliaz, Isaac, Weil, Elaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268168/ https://www.ncbi.nlm.nih.gov/pubmed/32482152 http://dx.doi.org/10.1177/1534735420922615 |
Ejemplares similares
-
Synergistic Antioxidant and Anti-Inflammatory Effects between Modified Citrus Pectin and Honokiol
por: Ramachandran, Cheppail, et al.
Publicado: (2017) -
Honokiol suppresses metastasis of renal cell carcinoma by targeting KISS1/KISS1R signaling
por: CHENG, SHUJIE, et al.
Publicado: (2015) -
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
por: Bonner, Michael Y., et al.
Publicado: (2016) -
Honokiol in glioblastoma recurrence: a case report
por: Wang, Ce, et al.
Publicado: (2023) -
Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
por: Hsiao, Yai-Ping, et al.
Publicado: (2020)